| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 1903B9Q6PI |
| InChI Key | HOKKHZGPKSLGJE-GSVOUGTGSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C5H9NO4 |
| Molecular Weight | 147.13 |
| AlogP | -0.87 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 86.63 |
| Molecular species | ZWITTERION |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 10.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | - | 19.05 | |
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S1A subfamily
|
- | 2420 | - | - | - | |
|
Enzyme
Protease
Serine protease
|
- | 2420 | - | - | - | |
|
Enzyme
Transferase
|
- | - | - | - | 9.071-20.46 | |
|
Ion channel
Ligand-gated ion channel
Ionotropic glutamate receptor
NMDA receptor
|
6860-75000 | 4150-35000 | - | 6200-6200 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 101.62 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Borderline Personality Disorder | 2 | D001883 | ClinicalTrials |
| Depressive Disorder, Major | 2 | D003865 | ClinicalTrials |
| Brain Injuries | 1 | D001930 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 31882 |
| ChEMBL | CHEMBL291278 |
| EPA CompTox | DTXSID8041082 |
| FDA SRS | 1903B9Q6PI |
| Human Metabolome Database | HMDB02393 |
| Guide to Pharmacology | 4268 |
| KEGG | C12269 |
| PDB | OEM |
| PubChem | 22880 |
| SureChEMBL | SCHEMBL2220 |
| ZINC | ZINC000000901012 |